Päivi Östling

I specialize in precision cancer medicine at SciLifeLab and the Department of Oncology-Pathology at Karolinska Institutet (KI). My work focuse on individualized drug profiling and spatial mapping of bladder cancer, in collaboration with Anders Ullén (K and KI OnkPat), Charlotte Stadler (KTH and Spatial Biology unit SciLifeLab), as well as the Olli Kallioniemi research group (KI OnkPat). Since the pandemic, I have also been involved in drug repurposing for infectious diseases with the Remedi4All consortium. As co-lead of the PCM Program at KI, I aim to accelerate the implementation of precision cancer medicine (PCM) and foster cross-disciplinary exchange. I co-organize a national PCM course for MD-PhD students, showcasing SciLifeLab technologies, clinical examples, and early clinical trial concepts. This course emphasizes the importance of multidisciplinary teams in PCM research. 

As the Scientific Lead of Precision Medicine at SciLifeLab, my role is to advance next-generation precision medicine infrastructure. I hold key positions in Swedish Life Science, including SWELife, Cancer Research KI, Karolinska Comprehensive Cancer Center Board, Genomic Medicine Sweden, and the PREDICT biobank. My extensive experience in research and strategic roles is invaluable for advancing precision medicine. Together with the Precision Medicine Team, I lead two major infrastructure projects: one on advancing clinical trials and the TEF-Health project, which supports Health AI providers across Europe.